Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Autor: Neller MA; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ambalathingal GR; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Sasadeusz J; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Pearson R; Department of Haematology, St Vincent's Hospital, School of Clinical Medicine, University of New South Wales and School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia., Holmes-Liew CL; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Singhal D; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Tunbridge M; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Ng WY; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Sharplin K; Royal Adelaide Hospital, Adelaide, South Australia, Australia., Moore A; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Deambrosis D; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Soosay-Raj T; Queensland Children's Hospital, South Brisbane, Queensland, Australia., McNaughton P; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Whyte M; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Fraser C; Queensland Children's Hospital, South Brisbane, Queensland, Australia., Grigg A; Austin Hospital, Heidelberg, Victoria, Australia., Kliman D; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Bajel A; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Cummins K; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Dowling M; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Yeoh ZH; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Harrison SJ; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Khot A; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Tan S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Roos I; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Koo RM; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Dohrmann S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Ritchie D; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Royal Melbourne Hospital, Parkville, Victoria, Australia., Wainstein B; Sydney Children's Hospital, Randwick, New South Wales, Australia., McCleary K; Sydney Children's Hospital, Randwick, New South Wales, Australia., Nelson A; Sydney Children's Hospital, Randwick, New South Wales, Australia., Gardiner B; The Alfred Hospital, Melbourne, Victoria, Australia., Inam S; The Alfred Hospital, Melbourne, Victoria, Australia., Badoux X; St George Public Hospital, Kogarah, New South Wales, Australia., Ma K; Westmead Hospital, Westmead, New South Wales, Australia., Toro C; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Hanna D; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Hughes D; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Conyers R; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Cole T; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Wang SS; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Chee L; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Fleming J; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia., Irish A; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Purtill D; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Cooney J; Fiona Stanley Hospital, Murdoch, Western Australia, Australia., Shaw P; The Children's Hospital at Westmead, Westmead, New South Wales, Australia., Tey SK; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Hunt S; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Subramonia Pillai E; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., John G; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Ng M; Perth Children's Hospital, Nedlands, Western Australia, Australia., Ramachandran S; Perth Children's Hospital, Nedlands, Western Australia, Australia., Hopkins P; The Prince Charles Hospital, Chermside, Queensland, Australia.; The University of Queensland Medical School, Herston, Queensland, Australia., Chambers D; The Prince Charles Hospital, Chermside, Queensland, Australia., Campbell S; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Francis R; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Isbel N; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Marlton P; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Reddiex H; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Matthews KK; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Voogt M; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Panikkar A; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Beagley L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Rehan S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Best S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Raju J; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Le Texier L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Crooks P; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Solomon M; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Lekieffre L; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Srihari S; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Smith C; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Khanna R; Queensland Immunology Research Centre, Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Rajiv.Khanna@qimrberghofer.edu.au.

Publikováno v: Nature communications [Nat Commun] 2024 Dec 03; Vol. 15 (1), pp. 10339. Date of Electronic Publication: 2024 Dec 03.

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome.

Autor: Loo S; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia.; Department of Haematology, The Alfred Hospital, Melbourne, Australia., Dillon R; Guy's and St Thomas Hospital, London, United Kingdom.; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Ivey A; Department of Pathology, The Alfred Hospital, Melbourne, Australia., Anstee NS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Haematology, The Alfred Hospital, Melbourne, Australia., Othman J; Guy's and St Thomas Hospital, London, United Kingdom.; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Tiong IS; Department of Haematology, The Alfred Hospital, Melbourne, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia., Potter N; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Jovanovic J; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Runglall M; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Chong CC; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Haematology, The Alfred Hospital, Melbourne, Australia., Bajel A; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia., Ritchie D; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia., Gray K; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia., Yeoh ZH; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia., McBean M; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia., Gilkes A; Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom., Thomas I; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Johnson S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Russell NH; Guy's and St Thomas Hospital, London, United Kingdom., Wei AH; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia.; Department of Haematology, The Alfred Hospital, Melbourne, Australia.

Publikováno v: Blood [Blood] 2022 Dec 01; Vol. 140 (22), pp. 2407-2411.

New Drugs Bringing New Challenges to AML: A Brief Review.

Autor: Yeoh ZH; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia., Bajel A; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3000, Australia., Wei AH; Department of Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia.; Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC 3004, Australia.; Division of Blood Cells and Blood Cancers, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia.

Publikováno v: Journal of personalized medicine [J Pers Med] 2021 Oct 03; Vol. 11 (10). Date of Electronic Publication: 2021 Oct 03.